Piramal Pharma's Stock Sees -3.73% Decline, MarketsMOJO Recommends 'Hold' Amidst Market Fluctuations

Piramal Pharma, a leading pharmaceutical company in the largecap industry, saw a decline of -3.73% in its stock on November 8th, 2024. This underperformance was noted by MarketsMOJO, who have given a 'Hold' call for the stock. The stock has been on a consecutive fall for the past two days, with a decline of -4.21% during this period. On the day of the report, the stock touched an intraday low of Rs 281, which is a decrease of -3.8%. Despite this recent decline, Piramal Pharma is still trading higher than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages. This indicates that the stock has been performing well in the long term. In comparison to the overall market performance, Piramal Pharma's stock has underperformed with a -3.71% decrease, while the Sensex has only seen a -0.08% decline. However, in the past month, Piramal Pharma has outperformed the Sensex with a 25.42% increase, while the Sensex has seen a -2.64% decline. Piramal Pharma continues to be a strong player in the pharmaceutical industry, with its stock showing resilience in the long term despite recent market fluctuations. Investors are advised to hold onto their positions for now, as suggested by MarketsMOJO.